Japan's Kaneka Corporation has begun sales of its i-ED COIL™, a brain aneurysm embolisation coil, in Europe as of October. 2025 The product obtained EC certification under an EU Medical Device Regulation in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V.
The i-ED COIL™ provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes. Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily.
Kaneka is expanding its business in a wide range of fields, which include devices for the treatment of cardiac, peripheral vascular, and cerebrovascular diseases, as well as medical devices used in the treatment of gastrointestinal tract diseases. Looking ahead, the company aims to strengthen the global reach of products such as i-ED COIL™ and achieve sales of 300 billion yen by 2030 in the Health Care Solution Unit including these medical businesses.
